Mean Corpuscular Hemoglobin (MCH) is a calculated red blood cell index on a standard complete blood count (CBC) that estimates the average “weight” of hemoglobin inside a single red blood cell. Hemoglobin is the iron-rich protein that binds oxygen in the lungs and delivers it to tissues. MCH is derived by dividing total hemoglobin by the red blood cell count, giving a snapshot of how well each cell is loaded for oxygen delivery.

MCH is calculated using values already included in a CBC: total hemoglobin and the number of red blood cells (RBC count). The lab computes MCH by dividing hemoglobin by RBC count to estimate the average amount of hemoglobin per red blood cell. Because it’s a calculated index, MCH typically has minimal lab-to-lab variation, but it should still be interpreted in context with other red cell indices for the most accurate assessment.

Normal MCH values typically range from about 27 to 33 picograms (pg) per cell. Within that reference range, “optimal” function is often described as being in the middle of the span, and the context also notes optimal values can sit in the mid to upper portion of the range. A normal or optimal MCH generally suggests red blood cells are carrying an appropriate amount of hemoglobin for efficient tissue oxygenation and stable energy metabolism.

Low MCH means each red blood cell carries less hemoglobin than normal, so oxygen delivery per cell drops. This pattern is most commonly linked to iron deficiency or chronic inflammation, and it can also occur with inherited conditions like thalassemia trait. Low MCH can help clarify symptoms such as fatigue, weakness, pale skin, shortness of breath, and difficulty concentrating - especially when other tests seem normal - because it points to underfilled red cells.

The most common causes of low MCH are iron deficiency (from inadequate intake, poor absorption, or chronic blood loss) and chronic inflammation, which can impair iron availability for red blood cell production. Inherited hemoglobin disorders such as thalassemia trait can also produce low MCH by altering red cell formation and hemoglobin content. Women of reproductive age are particularly vulnerable due to menstrual blood loss, and children may show growth or school performance issues.

High MCH indicates red blood cells contain more hemoglobin per cell, often because the cells are larger (commonly alongside a higher MCV). A classic cause is vitamin B12 or folate deficiency, where slowed DNA synthesis leads to fewer divisions and bigger, hemoglobin-rich red cells. High MCH can be associated with symptoms like weakness, memory problems, numbness or tingling in hands and feet, and balance issues, especially in older adults.

Elevated MCH can occur with liver disease or hypothyroidism, conditions that can alter red blood cell production and lead to larger, hemoglobin-heavy cells. Certain medications that affect folate metabolism can also raise MCH by disrupting normal red cell maturation. Because MCH reflects the average hemoglobin per cell, these conditions may shift MCH upward even when the root issue is metabolic or hormonal rather than iron-related, so it’s important to interpret patterns across the CBC.

MCH rarely stands alone; it’s best read with other red cell indices to understand size and hemoglobin patterns. MCV helps identify whether red cells are small or large, while MCHC reflects hemoglobin concentration within cells. The red blood cell count adds context to overall cell production. Together, these CBC components help distinguish iron deficiency (often low MCH) from vitamin B12/folate deficiency (often high MCH with high MCV) and other blood disorders.

Pregnancy can transiently alter MCH interpretation, and anemia during pregnancy can affect maternal energy and fetal growth. MCH testing supports healthy pregnancy by helping detect anemia and nutrient-related issues early, including iron deficiency or vitamin B12/folate imbalance that impacts red blood cell hemoglobin content. By identifying whether red cells are underfilled or oversized, MCH - interpreted with MCV and RBC count - can help guide more targeted nutritional or therapeutic support.

MCH can guide targeted treatment by indicating whether red cells are carrying too little hemoglobin (often supporting iron evaluation and treatment) or showing patterns consistent with vitamin B12/folate deficiency (often with larger cells). After starting therapy, trending MCH over time helps track response and confirm that red blood cell hemoglobin loading is improving. Monitoring MCH alongside MCV and related CBC indices can show whether anemia therapy is working and whether oxygen delivery capacity is recovering.